Jpmorgan Chase & CO Novo Cure LTD Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Novo Cure LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 123,656 shares of NVCR stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

123,656

Previous 109,087 13.36%

Holding current value

$2.05 Million

Previous $1.71 Million 24.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$11.83 - $24.05 $172,351 - $350,384	14,569 Added 13.36%	123,656 $2.12 Million
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $487,485 - $678,632	-39,250 Reduced 26.46%	109,087 $1.71 Million
Q4 2023 Feb 12, 2024	SELL	$11.13 - $15.78 $2.4 Million - $3.4 Million	-215,472 Reduced 59.23%	148,337 $2.21 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $3.73 Million - $9.77 Million	230,748 Added 173.42%	363,809 $5.88 Million
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $7.73 Million - $15.8 Million	-191,883 Reduced 59.05%	133,061 $5.52 Million
Q1 2023 May 18, 2023	BUY	$56.44 - $118.81 $210,182 - $442,448	3,724 Added 1.16%	324,944 $19.5 Million
Q1 2023 May 11, 2023	BUY	$56.44 - $118.81 $587,879 - $1.24 Million	10,416 Added 3.35%	321,220 $19.3 Million
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $6.1 Million - $8.14 Million	95,343 Added 44.25%	310,804 $22.8 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $384,823 - $506,966	-5,660 Reduced 2.56%	215,461 $16.4 Million
Q2 2022 Aug 11, 2022	SELL	$56.6 - $89.9 $5.37 Million - $8.52 Million	-94,808 Reduced 30.01%	221,121 $15.4 Million
Q1 2022 May 11, 2022	BUY	$60.15 - $84.52 $4.49 Million - $6.31 Million	74,642 Added 30.93%	315,929 $26.2 Million
Q4 2021 Feb 10, 2022	BUY	$75.08 - $121.99 $15.1 Million - $24.5 Million	200,864 Added 496.91%	241,287 $18.1 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $4.7 Million - $7.86 Million	40,423 New	40,423 $4.7 Million

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

78.7M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.74B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Novo Cure LTD Transaction History